<p>Impact of vitamin D on spirometry findings and quality of life in patients with chronic obstructive pulmonary disease: a randomized, double-blinded, placebo-controlled clinical trial</p>

Ali Alavi Foumani, Mojtaba Mehrdad, Alireza Jafarinezhad, Khadijeh Nokani, Alireza Jafari

International Journal of COPD · 2019 · 37 citations · 15 references

DOIFull text

Open access

Concepts

Abstract

Abstract: COPD is an irreversible chronic illness with airflow limitation. The aim of the current study was to assess the role of vitamin D 3 on quality of life and pulmonary function in patients with COPD. A randomized, double-blinded clinical trial was conducted in 63 patients with COPD. Patients were placed into intervention and placebo groups. Each individual in the intervention group took 50,000 IU vitamin D 3 once a week for 8 weeks and then once a month for 4 months. There was no significant difference among FEV 1 , FEV 1 /FVC, and number of exacerbations in patients with COPD ( P >0.05). In the intervention group, a significant difference was observed in quality of life at 2 months ( P <0.001) and 6 months ( P <0.001). In addition, qualitative analysis showed that the status of exacerbation had not got worse six months after initiation in the intervention group. The current study shows that consumption of 50,000 IU vitamin D 3 , as a convenient supplementation in a daily diet, is able to increase quality of life in patients with COPD. Keywords: airflow obstruction, chronic, 25-hydroxyvitamin D 3 , life quality

References

15